P
Pauline Brice
Researcher at University of Paris
Publications - 243
Citations - 14207
Pauline Brice is an academic researcher from University of Paris. The author has contributed to research in topics: Brentuximab vedotin & Follicular lymphoma. The author has an hindex of 56, co-authored 227 publications receiving 12729 citations.
Papers
More filters
Journal ArticleDOI
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
Gilles Salles,Nicolas Mounier,Sophie de Guibert,Franck Morschhauser,Chantal Doyen,Jean-François Rossi,Corinne Haioun,Pauline Brice,Beatrice Mahe,Reda Bouabdallah,Bruno Audhuy,Christophe Fermé,Caroline Dartigeas,Pierre Feugier,Catherine Sebban,Luc Xerri,Charles Foussard +16 more
TL;DR: With a 5-year follow-up, the combination of rituximab with CHVP+I provides superior disease control in follicular lymphoma patients despite a shorter duration of chemotherapy.
Journal ArticleDOI
Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers,Marc André,Massimo Federico,Theodore Girinsky,Reman Oumedaly,Ercole Brusamolino,Pauline Brice,Christophe Fermé,Richard W.M. van der Maazen,Manuel Gotti,Reda Bouabdallah,Catherine Sebban,Yolande Lievens,Allessandro Re,Aspasia Stamatoullas,F. Morschhauser,Pieternella J. Lugtenburg,Elisabetta Abruzzese,Pierre Olivier,Rene-Olivier Casasnovas,Gustaaf W. van Imhoff,Tiana Raveloarivahy,Monica Bellei,Thierry Van der Borght,Stéphane Bardet,Annibale Versari,Martin Hutchings,Michel Meignan,Catherine Fortpied +28 more
TL;DR: Combined-modality treatment resulted in fewer early progressions in clinical stage I/II HL, although early outcome was excellent in both arms.
Journal ArticleDOI
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
Felix Reyes,Eric Lepage,Gérard Ganem,Thierry Jo Molina,Pauline Brice,Bertrand Coiffier,Pierre Morel,Christophe Fermé,André Bosly,Pierre Lederlin,Guy Laurent,Hervé Tilly +11 more
TL;DR: In patients under 61 years of age, chemotherapy with three cycles of ACVBP followed by sequential consolidation is superior toThree cycles of CHOP plus radiotherapy for the treatment of low-risk localized lymphoma.
Journal ArticleDOI
Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
Philippe Solal-Celigny,Eric Lepage,Nicole Brousse,Felix Reyes,Corinne Haioun,Michel Leporrier,Michel Peuchmaur,André Bosly,Yolaine Parlier,Pauline Brice,Bertrand Coiffier,Christian Gisselbrecht +11 more
TL;DR: The addition of interferon alfa to a regimen containing doxorubicin increased the rate of response, event-free survival, and overall survival in patients with advanced follicular non-Hodgkin's lymphoma, without serious toxicity, although some patients were unable to tolerate the side effects.
Journal ArticleDOI
Extranodal Hodgkin disease: spectrum of disease.
Ali Guermazi,Pauline Brice,Eric de Kerviler,Christophe Fermé,Christophe Hennequin,Véronique Meignin,Jacques Frija +6 more
TL;DR: Computed tomography (CT) is the preferred modality for evaluating hepatic lymphoma and has proved particularly valuable in diagnosing gastric lymph cancer and detecting renal or perirenal masses, although ultrasonography and magnetic resonance imaging may also be helpful.